Shares of pSivida Corp. (NASDAQ:PSDV) shot up 6.7% during mid-day trading on Thursday . The stock traded as high as $3.64 and last traded at $3.48, with a volume of 425,912 shares trading hands. The stock had previously closed at $3.26.

Separately, FBR & Co reissued a “buy” rating and issued a $7.00 price target on shares of pSivida Corp. in a research report on Thursday, June 23rd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. pSivida Corp. currently has a consensus rating of “Hold” and a consensus price target of $7.00.

The stock’s market cap is $117.21 million. The stock has a 50-day moving average price of $3.23 and a 200-day moving average price of $3.15.

pSivida Corp. (NASDAQ:PSDV) last released its quarterly earnings data on Thursday, May 5th. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.05. On average, analysts anticipate that pSivida Corp. will post ($0.62) earnings per share for the current fiscal year.

pSivida Corp. is a biotechnology company, which is engaged in the development of sustained-release drug-delivery products for treating eye diseases. The Company offers products for treatment of back-of-the-eye diseases. The Company’s lead development product, Medidur is used for posterior of the eye (posterior uveitis).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.